Regen BioPharma News Headlines

Today's Range N/A
50-Day Range
52-Week Range N/A
Volume31.84 million shs
Average Volume207.31 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Regen BioPharma (OTCMKTS RGBP) News Headlines Today

Regen BioPharma Inc.Regen BioPharma Inc.
barrons.com - June 20 at 12:46 AM
Regen BioPharma, Inc. (RGBPP)Regen BioPharma, Inc. (RGBPP)
finance.yahoo.com - June 18 at 12:38 AM
Regen BioPharma, Inc. (OTCMKTS:RGBP) Short Interest UpdateRegen BioPharma, Inc. (OTCMKTS:RGBP) Short Interest Update
americanbankingnews.com - June 13 at 12:30 PM
Hematopoietic Stem Cell Transplant Market Global Industry Demand, Innovative, Research Report, Future Estimation And Forecast[2029]Hematopoietic Stem Cell Transplant Market Global Industry Demand, Innovative, Research Report, Future Estimation And Forecast[2029]
marketwatch.com - May 14 at 1:28 PM
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.